RPL24

Across TCGA pan-cancer cohorts, RPL24 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated RPL24 data layer compared with 1 for mutation status and 7 for mass-spec protein.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RPL24 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPL24 expression acts as an unfavorable survival marker, although some lineages such as UVM and LGG show a favorable association.

LIHC, ACC, and UVM are the cancer types where RPL24 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Median	III,IV	0.492	0.785	<.001	64	view →
ACC	DFS	Tertile	All	0.256	0.708	<.001	62	view →
UVM	DFS	Median	II,III,IV	0.759	0.430	<.001	59	view →
LGG	DFS	Median	All	0.812	0.651	<.001	41	view →
SCLC	DFS	Quartile	All	0.308	0.753	<.001	29	view →
UCEC	DFS	Median	IV	0.509	0.822	.008	20	view →
MESO	DFS	Median	III,IV	0.600	0.292	.021	18	view →
TGCT	DFS	Median	All	0.742	0.921	.002	16	view →
KICH	DFS	Tertile	All	0.725	1.000	.010	15	view →
THCA	DFS	Median	All	0.919	0.763	.001	15	view →
KIRP	DFS	Tertile	All	0.850	0.963	.008	14	view →
HNSC	DFS	Tertile	All	0.568	0.680	.019	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

RPL24–LIHC (OS)

Open the LIHC breakdown →